Fung-Leung WP - Search Results

1

Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation.

Ling P, Ngo K, Nguyen S, Thurmond RL, Edwards JP, Karlsson L, Fung-Leung WP. Ling P, et al. Br J Pharmacol. 2004 May;142(1):161-71. doi: 10.1038/sj.bjp.0705729. Br J Pharmacol. 2004. PMID: 15131002 Free PMC article.

2

A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties.

Thurmond RL, Desai PJ, Dunford PJ, Fung-Leung WP, Hofstra CL, Jiang W, Nguyen S, Riley JP, Sun S, Williams KN, Edwards JP, Karlsson L. Thurmond RL, et al. J Pharmacol Exp Ther. 2004 Apr;309(1):404-13. doi: 10.1124/jpet.103.061754. Epub 2004 Jan 13. J Pharmacol Exp Ther. 2004. PMID: 14722321

3

Histamine H4 receptor antagonists: the new antihistamines?

Fung-Leung WP, Thurmond RL, Ling P, Karlsson L. Fung-Leung WP, et al. Curr Opin Investig Drugs. 2004 Nov;5(11):1174-83. Curr Opin Investig Drugs. 2004. PMID: 15573868 Review.

4

Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivo.

Cowden JM, Yu F, Challapalli M, Huang JF, Kim S, Fung-Leung WP, Ma JY, Riley JP, Zhang M, Dunford PJ, Thurmond RL. Cowden JM, et al. Inflamm Res. 2013 Jun;62(6):599-607. doi: 10.1007/s00011-013-0612-5. Epub 2013 Mar 27. Inflamm Res. 2013. PMID: 23532396 Free PMC article.

5

Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells.

Hofstra CL, Desai PJ, Thurmond RL, Fung-Leung WP. Hofstra CL, et al. J Pharmacol Exp Ther. 2003 Jun;305(3):1212-21. doi: 10.1124/jpet.102.046581. Epub 2003 Mar 6. J Pharmacol Exp Ther. 2003. PMID: 12626656

6

Behavioral characterization of mice lacking histamine H(3) receptors.

Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW. Toyota H, et al. Mol Pharmacol. 2002 Aug;62(2):389-97. doi: 10.1124/mol.62.2.389. Mol Pharmacol. 2002. PMID: 12130692

7

A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling.

Rao N, Nguyen S, Ngo K, Fung-Leung WP. Rao N, et al. Mol Cell Biol. 2005 Aug;25(15):6521-32. doi: 10.1128/MCB.25.15.6521-6532.2005. Mol Cell Biol. 2005. PMID: 16024789 Free PMC article.

8

Immunological characterization of HM5023507, an orally active PI3Kδ/γ inhibitor.

Cai Y, Yu J, Ren P, He J, Wu Z, Xiao K, Jia H, Wang J, Sai Y, Dai G, Li X, Su W, Ngo K, Castro G, Acton PD, Fung-Leung WP, Edwards JP, Venable J, Rao TS. Cai Y, et al. Among authors: fung leung wp. Pharmacol Res Perspect. 2020 Jan 13;8(1):e00559. doi: 10.1002/prp2.559. eCollection 2020 Feb. Pharmacol Res Perspect. 2020. PMID: 31956418 Free PMC article.

9

Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse.

Eckert WA 3rd, Wiener JJM, Cai H, Ameriks MK, Zhu J, Ngo K, Nguyen S, Fung-Leung WP, Thurmond RL, Grice C, Edwards JP, Chaplan SR, Karlsson L, Sun S. Eckert WA 3rd, et al. Among authors: fung leung wp. Eur J Pharmacol. 2020 Aug 5;880:173171. doi: 10.1016/j.ejphar.2020.173171. Epub 2020 May 11. Eur J Pharmacol. 2020. PMID: 32437743

10

Phosphoinositide 3-kinase gamma (PI3Kgamma) inhibitors for the treatment of inflammation and autoimmune disease.

Venable JD, Ameriks MK, Blevitt JM, Thurmond RL, Fung-Leung WP. Venable JD, et al. Recent Pat Inflamm Allergy Drug Discov. 2010 Jan;4(1):1-15. doi: 10.2174/187221310789895603. Recent Pat Inflamm Allergy Drug Discov. 2010. PMID: 20017720 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters